Citigroup’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-81,578
| Closed | -$4.16M | – | 5097 |
|
|
2024
Q4 | $4.16M | Buy |
81,578
+16,096
| +25% | +$822K | ﹤0.01% | 1572 |
|
|
2024
Q3 | $2.7M | Buy |
65,482
+27,919
| +74% | +$1.15M | ﹤0.01% | 1813 |
|
|
2024
Q2 | $1.81M | Buy |
37,563
+5,016
| +15% | +$242K | ﹤0.01% | 1834 |
|
|
2024
Q1 | $1.56M | Sell |
32,547
-8,112
| -20% | -$389K | ﹤0.01% | 2017 |
|
|
2023
Q4 | $2.64M | Buy |
40,659
+3,118
| +8% | +$202K | ﹤0.01% | 1455 |
|
|
2023
Q3 | $2.46M | Buy |
37,541
+18,002
| +92% | +$1.18M | ﹤0.01% | 1369 |
|
|
2023
Q2 | $1.14M | Buy |
19,539
+13,572
| +227% | +$789K | ﹤0.01% | 2159 |
|
|
2023
Q1 | $368K | Sell |
5,967
-1,382
| -19% | -$85.3K | ﹤0.01% | 2737 |
|
|
2022
Q4 | $467K | Sell |
7,349
-5,504
| -43% | -$350K | ﹤0.01% | 2581 |
|
|
2022
Q3 | $933K | Buy |
12,853
+5,645
| +78% | +$410K | ﹤0.01% | 2165 |
|
|
2022
Q2 | $491K | Buy |
7,208
+1,489
| +26% | +$101K | ﹤0.01% | 2626 |
|
|
2022
Q1 | $518K | Sell |
5,719
-7,277
| -56% | -$659K | ﹤0.01% | 2820 |
|
|
2021
Q4 | $1.19M | Buy |
12,996
+4,795
| +58% | +$438K | ﹤0.01% | 2388 |
|
|
2021
Q3 | $665K | Sell |
8,201
-119
| -1% | -$9.65K | ﹤0.01% | 2710 |
|
|
2021
Q2 | $777K | Buy |
8,320
+870
| +12% | +$81.2K | ﹤0.01% | 2796 |
|
|
2021
Q1 | $798K | Buy |
7,450
+15
| +0.2% | +$1.61K | ﹤0.01% | 2532 |
|
|
2020
Q4 | $649K | Buy |
7,435
+5,319
| +251% | +$464K | ﹤0.01% | 2474 |
|
|
2020
Q3 | $146K | Buy |
+2,116
| New | +$146K | ﹤0.01% | 2935 |
|